We are looking for individuals to participate in a study that looks at the relationship between endorphins in plasma and human immunodeficiency virus (HIV) associated chronic pain. To participate in this study we are looking for people with or without HIV between the ages of 19 and 64 years old, free from serious medical conditions, and able to come to two testing sessions one week apart. Participants will receive up to $200 for completing the study. You may not be eligible to participate if you have significant health problems, are pregnant, or are taking certain medications. Please email, jxjuncos@uabmc.edu, or call 205-934-6609. Leave a short message with your name, number and mention that you are interested in the Chronic Widespread Pain in HIV study.

Help us find out by joining our study at UAB. You may be eligible to participate in the PRECISION-BP research study about the effects of Sacubitril/Valsartan or Valsartan on your body’s 24-hour rhythm of a hormone in your blood called natriuretic peptides. This hormone and the study medications are related to the heart. Eligible participants must have a BMI: 30-45 kg/m2), have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Nehal at PRECISION-BPSTUDY@uabmc.edu or call us at 205-934-7173 if you are interested

Throughout Wellness Week Oct. 17-21, employees and students from across UAB and UAB Medicine shared dozens of photos and videos that represent what wellness means to them. 

During the first few months of a semester, students can accumulate more questions about life as a Blazer than they had when they started. Discover resources for students spanning financial aid assistance, mental health, career prep and more.

The purpose of this research study is to better understand the long-term effects of COVID-19, and who is at greatest risk of having long-term effects. We will do this by studying people with, and without, a history of COVID-19 over several years. This is part of a nation-wide research initiative called RECOVER. If you are interested contact COVID-19research@uabmc.edu

This study will last up to four years and will involve doing in-person visits every 6 months and filling out an online questionnaire from home every 3 months. At the first study visit you will be asked a series of questions or fill out a questionnaire about who you are (such as age, sex, or race), medical conditions that may affect the chances of having long-term effects of COVID-19, whether you have been vaccinated against COVID-19, and any symptoms you currently have. You will have a brief medical exam and we will also collect samples of your blood, saliva, stool, nasal swab and urine. Some participants will be invited for additional medical examinations and tests. You will be compensated.

Carol Ballinger, Dylan McDonald and Robert Welch are the second-quarter honorees of the UAB Shared Values in Action Program, which honors those whose work exemplifies and embodies Forging the Future's shared values.

Amber Anderson, Kristen Campbell, Jamye Hester, Kevin Speed and Donna Williamson are the third-quarter honorees of the UAB Shared Values in Action Program, which honors those whose work exemplifies and embodies Forging the Future's shared values.

The Targeted Exercise for African Americans with Multiple Sclerosis (TEAAMS) study will examine whether a 16-week home-based, racially-tailored exercise training program can provide improvements in walking dysfunction, symptoms, and quality of life among Black/African Americans with MS who live in rural communities in the Southeastern US. Eligible participants must be 18-64 years old, diagnosed with MS, self-identify as Black or African American, and live in the Southeastern US. Participants will be compensated $90 for completing all study visits. Please contact Edson Flores at enrl@uic.edu or (833) 727-1887 for more information and to see if you qualify.

Adult ages 40-80 are needed for a study about the anti-inflammatory effects of ensifentrine in patients with COPD. The study involves 7 visits in our clinical research unit, and the collection of urine and blood. Compensation up to $700. For more information, call 205-996-2727 or email Carrie at LungHealth@uabmc.edu.

Help us find out by joining our study. The University of Alabama at Birmingham, Department of Nutrition Sciences, is conducting an exciting research study, in collaboration with Pennington Biomedical Research Center, to investigate whether intermittent fasting or calorie restriction (i.e., losing weight) can improve health and slow the aging process.

If you are randomly selected to do calorie restriction, you may lose weight by eating less. If you are randomly selected to do intermittent fasting, you will fast for 16 hours per day and eat dinner by 6 pm about 6 days per week (1 break day per week). We want you to be successful: the study provides intensive coaching and support to help you successfully lose weight or practice intermittent fasting.

To qualify, you should:

Be 25-45 years old
Have a BMI between 22-30 Calculate your BMI here
Be healthy
Not currently taking any medications or supplements for chronic conditions
Not smoke, vape, or use tobacco products currently or within the last 6 months
Not currently participate in a regular program of heavy physical activity (e.g., jogging, running, or riding fast on a bicycle for 30 minutes or more per day)
The study involves collecting a medical history, body fat and bone scans, blood draws, urine collection, questionnaires, and other simple tests. Participation in the study will last approximately 7 months. Compensation of up to $1,500 is offered for the completion of this study. If you are interested in participating and think you may be eligible, please click the button below to screen online, call 205-934-1457, or email dial@uab.edu.